Bleichroeder’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
Other funds holding DMAC
Bleichroeder's DMAC Position: Q3 2026 in Review
Bleichroeder held its DiaMedica Therapeutics (DMAC) position steady in Q3 2026 at 382,317 shares worth $3.16M. The position accounts for 0.31% of the portfolio, ranked #57.
Bleichroeder first reported a position in DMAC in Q2 2023 and has held it in 14 quarters since. 67 funds tracked by Wall St. Rank hold DMAC as of Q3 2026.
- Bleichroeder held 382,317 shares of DiaMedica Therapeutics worth $3.16M as of Q3 2026.
- Bleichroeder left its DiaMedica Therapeutics share count unchanged in Q3 2026.
- DiaMedica Therapeutics made up 0.31% of Bleichroeder's portfolio in Q3 2026, its #57 holding.
- Bleichroeder first reported a position in DiaMedica Therapeutics in Q2 2023 and has held it in 14 quarters since.
- 67 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2026.
Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.